KJWM
GHDX

Kiley Juergens Wealth Management’s Genomic Health, Inc. GHDX Stock Holding History

Kiley Juergens Wealth Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed -$7K – 755
2018
Q3 		$7K Hold
100
– – 0.01% 509
2018
Q2 		$5K Buy
+100
New +$3.97K ﹤0.01% 493
2018
Q1 		– Sell
-100
Closed -$3K – 684
2017
Q4 		$3K Buy
+100
New +$3.19K ﹤0.01% 622

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kiley Juergens Wealth Management's GHDX Position: Q4 2018 in Review

Kiley Juergens Wealth Management sold out of Genomic Health, Inc. (GHDX) in Q4 2018, closing a stake of 100 shares — an estimated $7K sold.

Kiley Juergens Wealth Management first reported a position in GHDX in Q4 2017 and held it in 3 quarters. The position peaked at $7K in Q3 2018. 228 funds tracked by Wall St. Rank hold GHDX as of Q4 2018.

  • Kiley Juergens Wealth Management reported no remaining Genomic Health, Inc. position as of Q4 2018 after selling out during the quarter.
  • Kiley Juergens Wealth Management sold 100 Genomic Health, Inc. shares in Q4 2018, an estimated $7K.
  • Kiley Juergens Wealth Management first reported a position in Genomic Health, Inc. in Q4 2017 and held it in 3 quarters.
  • Kiley Juergens Wealth Management's Genomic Health, Inc. position peaked at $7K in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2018.

Based on Kiley Juergens Wealth Management's 13F filing for Q4 2018, filed 15 Jan 2019.